A critical breakthrough in cancer investigation is occurring with the use of nanobodies to re-engage mutated p53. This crucial malignant protector protein is frequently inactivated in many forms of cancer, resulting https://socialmediainuk.com/story28253719/vhh-fragments-revive-the-p53-protein-the-promising-hope-for-malignant-therapy